|
Recorded Presentations from the NCCN 2025 Webinar Series - Optimizing Patient Outcomes: Collaborative Perspectives in Oncology |
|
03/10/2025 - 12:00am to 12/31/2026 - 12:00am |
|
NCCN Guidelines® Insights - Testicular Cancer, Version 2.2025 |
1.00 |
04/10/2025 - 12:00am to 04/10/2026 - 12:00am |
|
Recorded Presentation from Optimizing Patient Outcomes - Metastatic Castration-Resistant Prostate Cancer: Systemic Therapy Updates |
1.00 |
05/02/2025 - 12:00am to 05/02/2026 - 12:00am |
|
Archived NCCN Tumor Boards: T-Cell Engager Therapy for Diffuse Large B-Cell Lymphoma: Bispecific Antibodies for Relapsed/Refractory Disease |
1.00 |
05/06/2025 - 12:00am to 04/30/2026 - 12:00am |
|
NCCN Guidelines® Insights - Multiple Myeloma, Version 1.2025 |
1.00 |
05/10/2025 - 12:00am to 05/10/2026 - 12:00am |
|
Recorded Presentation from Optimizing Patient Outcomes - Targeted Therapies for Thyroid Carcinoma |
1.00 |
05/27/2025 - 12:00am to 05/27/2026 - 12:00am |
|
Archived NCCN Tumor Boards: New Approaches to the Management of Resectable Non-Small Cell Lung Cancer |
1.00 |
05/28/2025 - 12:00am to 05/22/2026 - 11:59pm |
|
Archived NCCN Tumor Boards: Treatment Options and Navigating Sequencing of Therapies in Relapsed/Refractory Multiple Myeloma |
1.00 |
05/28/2025 - 12:00am to 05/23/2026 - 11:59pm |
|
NCCN Guidelines® Insights - Survivorship, Version 2.2025 |
1.00 |
06/10/2025 - 12:00am to 06/10/2026 - 12:00am |
|
NCCN Guidelines® Insights - Thyroid Carcinoma, Version 1.2025 |
1.00 |
07/10/2025 - 12:00am to 07/10/2026 - 12:00am |
|
Recorded Presentation from Optimizing Patient Outcomes - Understanding the Mismatch Repair Deficient (dMMR)/Microsatellite-High (MSI-H) Treatment... |
1.00 |
07/29/2025 - 12:00am to 07/23/2026 - 12:00am |
|
NCCN Guidelines® Insights - Uterine Neoplasms, Version 3.2025 |
1.00 |
08/10/2025 - 12:00am to 08/10/2026 - 12:00am |
|
Archived NCCN Tumor Boards: Skin Cancers Except Melanoma - Radiation Therapy Treatment Options |
1.00 |
08/13/2025 - 12:00am to 07/31/2026 - 11:59pm |
|
Recorded Presentation from Optimizing Patient Outcomes - New Primary Therapy Options for Stage III-IV Hodgkin Lymphoma |
1.00 |
08/25/2025 - 12:00am to 08/13/2026 - 11:59pm |
|
Archived NCCN Tumor Boards: New and Emerging Systemic Therapy Options in Bladder Cancer |
1.00 |
09/05/2025 - 12:00am to 08/24/2026 - 11:59pm |
Facebook
X
LinkedIn
Forward